![]() |
|
|
Vol. 298, Issue 1, 103-109, July 2001
Division of Allergy, Immunology, and Rheumatology, Department of
Internal Medicine (D.Z., T.Y., S.A.B., J.S.T.), Department of Chemistry
and Center of Membrane Sciences (C.M.L., D.A.B.), University of
Kentucky, Lexington, Kentucky; Veterans Administration Medical Center,
Lexington, Kentucky (S.A.B., J.S.T.); and Division of Research,
Department of Pathology and Laboratory Medicine, Medical University of
South Carolina, Charleston, South Carolina (D.Z.)
Tricyclodecan-9-yl-xanthogenate (D609) has been extensively
studied in biological systems and exhibits a variety of biological functions, including antiviral, antitumor, and anti-inflammatory activities. Most of these activities have been largely attributed to
the inhibitory effect of D609 on phosphatidylcholine-specific phospholipase C. However, as a xanthate derivative, D609 is a strong electrolyte and readily dissociates to xanthate anions and
cations of alkali metals in solution. Xanthate anions and protonated
xanthic acid contain a free thiol moiety and are highly reductive. This
implies that D609 and other xanthate derivatives may function as potent
antioxidants. Indeed, we found that D609 inhibited the Fenton
reaction-induced oxidation of dihydrorhodamine 123 in a dose-dependent
manner similar to that of pyrrolidinedithiocarbamate, a well known
antioxidant. In addition, D609 inhibited the formation of the
-phenyl-tert-butylnitrone-free radical spin adducts
and lipid peroxidation of synaptosomal membranes by the Fenton
reagents. Furthermore, preincubation of lymphocytes with D609 resulted
in a significant diminution of ionizing radiation (IR)-induced 1) production of reactive oxygen species; 2) decrease in intracellular reduced glutathione; 3) oxidative damage to proteins and lipids; and 4)
activation of nuclear factor-
B. Moreover, when D609 (50 mg/kg i.v.)
was administered to mice 10 min prior to total body IR (6.5 and 8.5 Gy), it protected the mice from IR-induced lethality. Thus, these
results indicate that D609 is a potent antioxidant and has the ability
to inhibit IR-induced cellular oxidative stress.
This article has been cited by other articles:
![]() |
F. Sandra, M. Degli Esposti, K. Ndebele, P. Gona, D. Knight, M. Rosenquist, and R. Khosravi-Far Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alters Mitochondrial Membrane Lipids Cancer Res., September 15, 2005; 65(18): 8286 - 8297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bai, G. P. Meier, Y. Wang, C. Luberto, Y. A. Hannun, and D. Zhou Prodrug Modification Increases Potassium Tricyclo[5.2.1.02,6]-decan-8-yl Dithiocarbonate (D609) Chemical Stability and Cytotoxicity against U937 Leukemia Cells J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1051 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Perry and N. D. Ridgway The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609 J. Lipid Res., January 1, 2004; 45(1): 164 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Giron-Calle, K. Srivatsa, and H. J. Forman Priming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609) J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||